LPCN 1154A for Postpartum Depression
(BLOOM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this research study is to test the study drug, LPCN 1154A, as a possible treatment for postpartum depression (PPD). The trial aims to determine:
* If LPCN 1154A reduces depressive symptoms in subjects with severe PPD
* How well LPCN 1154A is tolerated and what side effects it may cause
Are You a Good Fit for This Trial?
This trial is for women who have recently given birth and are experiencing severe postpartum depression. Participants must meet certain health requirements, but specific inclusion or exclusion details were not provided.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- LPCN 1154A
Trial Overview
The study is testing a new drug called LPCN 1154A to see if it helps reduce symptoms of postpartum depression compared to a placebo (inactive treatment). Participants are randomly assigned to receive either the drug or placebo.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
LPCN 1154A Tablets
Placebo Tablets
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lipocine Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.